These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1676664)

  • 1. Metabolism of [14C]monocrotaline by isolated perfused rat liver.
    Lamé MW; Jones AD; Morin D; Segall HJ
    Drug Metab Dispos; 1991; 19(2):516-24. PubMed ID: 1676664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):1-8. PubMed ID: 7839357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion of pyrrolic metabolites of [14C]monocrotaline in the rat.
    Lamé MW; Jones AD; Morin D; Segall HJ; Wilson DW
    Drug Metab Dispos; 1995 Mar; 23(3):422-9. PubMed ID: 7628310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal metabolism of pyrrolizidine alkaloids from Senecio jacobaea. Isolation and quantification of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine and N-oxides by high performance liquid chromatography.
    Ramsdell HS; Kedzierski B; Buhler DR
    Drug Metab Dispos; 1987; 15(1):32-6. PubMed ID: 2881756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [14C]monocrotaline kinetics and metabolism in the rat.
    Estep JE; Lamé MW; Morin D; Jones AD; Wilson DW; Segall HJ
    Drug Metab Dispos; 1991; 19(1):135-9. PubMed ID: 1673386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
    Wang YP; Yan J; Beger RD; Fu PP; Chou MW
    Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9-Glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine Is the Major Pyrrolic Glutathione Conjugate of Retronecine-Type Pyrrolizidine Alkaloids in Liver Microsomes and in Rats.
    Chen M; Li L; Zhong D; Shen S; Zheng J; Chen X
    Chem Res Toxicol; 2016 Feb; 29(2):180-9. PubMed ID: 26761523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):58-63. PubMed ID: 8048054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.
    Williams DE; Reed RL; Kedzierski B; Dannan GA; Guengerich FP; Buhler DR
    Drug Metab Dispos; 1989; 17(4):387-92. PubMed ID: 2571477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of pyrrolizidine alkaloid metabolites from mouse liver microsomes using tandem mass spectrometry and gas chromatography/mass spectrometry.
    Winter CK; Segall HJ; Jones AD
    Biomed Environ Mass Spectrom; 1988 Mar; 15(5):265-73. PubMed ID: 3365497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
    Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline.
    Lamé MW; Morin D; Jones AD; Segall HJ; Wilson DW
    Toxicol Lett; 1990 May; 51(3):321-9. PubMed ID: 2111054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of dehydromonocrotaline with rat red blood cells.
    Lamé MW; Jones AD; Morin D; Wilson DW; Segall HJ
    Chem Res Toxicol; 1997 Jun; 10(6):694-701. PubMed ID: 9208177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
    Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP
    Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.